Anticancer Metallotherapeutics in Preclinical Development

Author(s): G. N. Kaluderovic, R. Paschke

Journal Name: Current Medicinal Chemistry

Volume 18 , Issue 31 , 2011

Become EABM
Become Reviewer
Call for Editor


This article reviews recent studies of platinum and other metal-containing antitumor drugs in preclinical development. A short overview of the development of cisplatin-based drug generations is given. Some pioneering strategies towards unconventional drugs, such as platinum complexes with biomolecules and carrier ligands, organoplatinum and multinuclear platinum complexes developed in recent years are outlined. Furthermore, nonplatinum-based antitumor drugs containing ruthenium(II/III), gallium(III), titanium(IV) or tin(IV) that illustrate the prominent strategies are presented with an emphasis on recent developments. In addition, alternatives for water insoluble drugs will be discussed. A brief overview of development of nanodrug delivery systems and their potential as alternative cancerostatic carriers are discussed.

Keywords: Anticancer metallotherapeutics, cisplatin, drug delivery system, gallium(III), liposomes, platinum(II), platinum(IV), nanomaterials, organoplatinum(IV), ruthenium(II), ruthenium(III), tin(IV), titanium(IV), transplatinum complexes

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2011
Page: [4738 - 4752]
Pages: 15
DOI: 10.2174/092986711797535308
Price: $65

Article Metrics

PDF: 20